Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FHLC vs. SWHFX: which is better?

Bottom line

FHLC vs SWHFX: the short answer

FHLC (Fidelity MSCI Health Care Index ETF) and SWHFX (Schwab Health Care Fund) share a meaningful slice of their top holdings — about 76% by weight.

But FHLC is far broader, holding 337 positions to 80 for SWHFX, so beyond the top names it adds exposure SWHFX doesn't have.

FHLC is cheaper at 0.084% vs 0.8% — a difference of $72 a year per $10,000 invested.

Over five years, FHLC returned +7.2% a year vs +6.5% for SWHFX (reporting dates differ).

Updated Nov 19, 2026

FHLC vs SWHFX side by side

FHLCSWHFX
TypeETFMutual fund
Fund familyFidelitySchwab
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.084%0.8%
Annual cost per $10k$8.4$80
10-yr cost on $10k (prospectus)$108$990
Max front loadNone—
12b-1 fee0%0%
1-yr return+2.6%+15.9%
5-yr return (annualized)+7.2%+6.5%
10-yr return (annualized)+8.8%+8.1%
Best quarter+16.4%+15.3%
Worst quarter−13.1%−12.1%
Net assets (fund)$3.3B$642.3M
Number of holdings33780
Portfolio turnover3%41%
Returns as ofNov 30, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFHLCSWHFXDifference
2024+2.6%+0.1%+2.5%
2023+2.5%+0.7%+1.8%
2022−5.5%−4.7%−0.8%
2021+20.4%+23.3%−2.9%
2020+18.1%+12.9%+5.3%
2019+21.9%+17.6%+4.3%
2018+5.5%+4.0%+1.5%
2017+23.3%+20.2%+3.1%
2016−3.3%−4.4%+1.0%

Source: Fund prospectus bar charts

Holdings overlap

17 of FHLC's top 25 holdings also appear in SWHFX's top 25.

Shared top holdings
HoldingFHLCSWHFX
Eli Lilly & Co13.35%13.92%
Johnson & Johnson8.93%6.94%
AbbVie Inc6.42%5.81%
UnitedHealth Group Inc5.44%4.74%
Merck & Co Inc4.66%4.98%
Thermo Fisher Scientific Inc3.09%2.16%
Amgen Inc3.00%2.58%
Abbott Laboratories2.66%1.60%
Gilead Sciences Inc2.34%3.24%
Bristol-Myers Squibb Co1.93%2.44%
Danaher Corp1.80%1.47%
Vertex Pharmaceuticals Inc1.76%1.89%
Stryker Corp1.62%2.11%
Medtronic PLC1.59%2.29%
Elevance Health Inc1.19%1.45%

Source: SEC Form N-PORT

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

SWHFX top 10

  1. Eli Lilly & Co — 13.92%
  2. Johnson & Johnson — 6.94%
  3. AbbVie Inc — 5.81%
  4. Merck & Co Inc — 4.98%
  5. UnitedHealth Group Inc — 4.74%
  6. Gilead Sciences Inc — 3.24%
  7. Novartis AG — 2.92%
  8. Amgen Inc — 2.58%
  9. Bristol-Myers Squibb Co — 2.44%
  10. Medtronic PLC — 2.29%

FAQ

What is the difference between FHLC and SWHFX?
FHLC (Fidelity MSCI Health Care Index ETF) and SWHFX (Schwab Health Care Fund) share a meaningful slice of their top holdings — about 76% by weight. But FHLC is far broader, holding 337 positions to 80 for SWHFX, so beyond the top names it adds exposure SWHFX doesn't have.
Which is cheaper, FHLC or SWHFX?
FHLC has the lower expense ratio (0.084%).
Should I own both FHLC and SWHFX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.